Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.

Identifieur interne : 006039 ( Main/Exploration ); précédent : 006038; suivant : 006040

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.

Auteurs : Kanchan Anand [Allemagne] ; John Ziebuhr ; Parvesh Wadhwani ; Jeroen R. Mesters ; Rolf Hilgenfeld

Source :

RBID : pubmed:12746549

Descripteurs français

English descriptors

Abstract

A novel coronavirus has been identified as the causative agent of severe acute respiratory syndrome (SARS). The viral main proteinase (Mpro, also called 3CLpro), which controls the activities of the coronavirus replication complex, is an attractive target for therapy. We determined crystal structures for human coronavirus (strain 229E) Mpro and for an inhibitor complex of porcine coronavirus [transmissible gastroenteritis virus (TGEV)] Mpro, and we constructed a homology model for SARS coronavirus (SARS-CoV) Mpro. The structures reveal a remarkable degree of conservation of the substrate-binding sites, which is further supported by recombinant SARS-CoV Mpro-mediated cleavage of a TGEV Mpro substrate. Molecular modeling suggests that available rhinovirus 3Cpro inhibitors may be modified to make them useful for treating SARS.

DOI: 10.1126/science.1085658
PubMed: 12746549


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.</title>
<author>
<name sortKey="Anand, Kanchan" sort="Anand, Kanchan" uniqKey="Anand K" first="Kanchan" last="Anand">Kanchan Anand</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Biochemistry, University of Lübeck, D-23538 Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Biochemistry, University of Lübeck, D-23538 Lübeck</wicri:regionArea>
<wicri:noRegion>23538 Lübeck</wicri:noRegion>
<wicri:noRegion>23538 Lübeck</wicri:noRegion>
<wicri:noRegion>D-23538 Lübeck</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ziebuhr, John" sort="Ziebuhr, John" uniqKey="Ziebuhr J" first="John" last="Ziebuhr">John Ziebuhr</name>
</author>
<author>
<name sortKey="Wadhwani, Parvesh" sort="Wadhwani, Parvesh" uniqKey="Wadhwani P" first="Parvesh" last="Wadhwani">Parvesh Wadhwani</name>
</author>
<author>
<name sortKey="Mesters, Jeroen R" sort="Mesters, Jeroen R" uniqKey="Mesters J" first="Jeroen R" last="Mesters">Jeroen R. Mesters</name>
</author>
<author>
<name sortKey="Hilgenfeld, Rolf" sort="Hilgenfeld, Rolf" uniqKey="Hilgenfeld R" first="Rolf" last="Hilgenfeld">Rolf Hilgenfeld</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:12746549</idno>
<idno type="pmid">12746549</idno>
<idno type="doi">10.1126/science.1085658</idno>
<idno type="wicri:Area/PubMed/Corpus">003402</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003402</idno>
<idno type="wicri:Area/PubMed/Curation">003402</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003402</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003284</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003284</idno>
<idno type="wicri:Area/Ncbi/Merge">000081</idno>
<idno type="wicri:Area/Ncbi/Curation">000081</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000081</idno>
<idno type="wicri:Area/Main/Merge">006538</idno>
<idno type="wicri:Area/Main/Curation">006039</idno>
<idno type="wicri:Area/Main/Exploration">006039</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.</title>
<author>
<name sortKey="Anand, Kanchan" sort="Anand, Kanchan" uniqKey="Anand K" first="Kanchan" last="Anand">Kanchan Anand</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Biochemistry, University of Lübeck, D-23538 Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Biochemistry, University of Lübeck, D-23538 Lübeck</wicri:regionArea>
<wicri:noRegion>23538 Lübeck</wicri:noRegion>
<wicri:noRegion>23538 Lübeck</wicri:noRegion>
<wicri:noRegion>D-23538 Lübeck</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ziebuhr, John" sort="Ziebuhr, John" uniqKey="Ziebuhr J" first="John" last="Ziebuhr">John Ziebuhr</name>
</author>
<author>
<name sortKey="Wadhwani, Parvesh" sort="Wadhwani, Parvesh" uniqKey="Wadhwani P" first="Parvesh" last="Wadhwani">Parvesh Wadhwani</name>
</author>
<author>
<name sortKey="Mesters, Jeroen R" sort="Mesters, Jeroen R" uniqKey="Mesters J" first="Jeroen R" last="Mesters">Jeroen R. Mesters</name>
</author>
<author>
<name sortKey="Hilgenfeld, Rolf" sort="Hilgenfeld, Rolf" uniqKey="Hilgenfeld R" first="Rolf" last="Hilgenfeld">Rolf Hilgenfeld</name>
</author>
</analytic>
<series>
<title level="j">Science (New York, N.Y.)</title>
<idno type="eISSN">1095-9203</idno>
<imprint>
<date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Chloromethyl Ketones (chemistry)</term>
<term>Amino Acid Chloromethyl Ketones (metabolism)</term>
<term>Amino Acid Sequence</term>
<term>Antiviral Agents</term>
<term>Binding Sites</term>
<term>Catalytic Domain</term>
<term>Coronavirus 229E, Human (enzymology)</term>
<term>Crystallization</term>
<term>Crystallography, X-Ray</term>
<term>Cysteine Endopeptidases (chemistry)</term>
<term>Cysteine Endopeptidases (metabolism)</term>
<term>Cysteine Proteinase Inhibitors (chemistry)</term>
<term>Cysteine Proteinase Inhibitors (metabolism)</term>
<term>Dimerization</term>
<term>Drug Design</term>
<term>Humans</term>
<term>Isoxazoles (chemistry)</term>
<term>Isoxazoles (metabolism)</term>
<term>Isoxazoles (pharmacology)</term>
<term>Models, Molecular</term>
<term>Molecular Sequence Data</term>
<term>Protein Conformation</term>
<term>Protein Structure, Secondary</term>
<term>Protein Structure, Tertiary</term>
<term>Pyrrolidinones (chemistry)</term>
<term>Pyrrolidinones (metabolism)</term>
<term>Pyrrolidinones (pharmacology)</term>
<term>Recombinant Proteins (chemistry)</term>
<term>Recombinant Proteins (metabolism)</term>
<term>SARS Virus (drug effects)</term>
<term>SARS Virus (enzymology)</term>
<term>Sequence Alignment</term>
<term>Sequence Homology, Amino Acid</term>
<term>Severe Acute Respiratory Syndrome (drug therapy)</term>
<term>Transmissible gastroenteritis virus (enzymology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Alignement de séquences</term>
<term>Antiviraux</term>
<term>Chlorométhyl cétones d'acides aminés ()</term>
<term>Chlorométhyl cétones d'acides aminés (métabolisme)</term>
<term>Conception de médicament</term>
<term>Conformation des protéines</term>
<term>Coronavirus humain 229E (enzymologie)</term>
<term>Cristallisation</term>
<term>Cristallographie aux rayons X</term>
<term>Cysteine endopeptidases ()</term>
<term>Cysteine endopeptidases (métabolisme)</term>
<term>Dimérisation</term>
<term>Domaine catalytique</term>
<term>Données de séquences moléculaires</term>
<term>Humains</term>
<term>Inhibiteurs de la cystéine protéinase ()</term>
<term>Inhibiteurs de la cystéine protéinase (métabolisme)</term>
<term>Isoxazoles ()</term>
<term>Isoxazoles (métabolisme)</term>
<term>Isoxazoles (pharmacologie)</term>
<term>Modèles moléculaires</term>
<term>Protéines recombinantes ()</term>
<term>Protéines recombinantes (métabolisme)</term>
<term>Pyrrolidones ()</term>
<term>Pyrrolidones (métabolisme)</term>
<term>Pyrrolidones (pharmacologie)</term>
<term>Similitude de séquences d'acides aminés</term>
<term>Sites de fixation</term>
<term>Structure secondaire des protéines</term>
<term>Structure tertiaire des protéines</term>
<term>Syndrome respiratoire aigu sévère (traitement médicamenteux)</term>
<term>Séquence d'acides aminés</term>
<term>Virus de la gastroentérite transmissible (enzymologie)</term>
<term>Virus du SRAS ()</term>
<term>Virus du SRAS (enzymologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Amino Acid Chloromethyl Ketones</term>
<term>Cysteine Endopeptidases</term>
<term>Cysteine Proteinase Inhibitors</term>
<term>Isoxazoles</term>
<term>Pyrrolidinones</term>
<term>Recombinant Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Amino Acid Chloromethyl Ketones</term>
<term>Cysteine Endopeptidases</term>
<term>Cysteine Proteinase Inhibitors</term>
<term>Isoxazoles</term>
<term>Pyrrolidinones</term>
<term>Recombinant Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr">
<term>Coronavirus humain 229E</term>
<term>Virus de la gastroentérite transmissible</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en">
<term>Coronavirus 229E, Human</term>
<term>SARS Virus</term>
<term>Transmissible gastroenteritis virus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Chlorométhyl cétones d'acides aminés</term>
<term>Cysteine endopeptidases</term>
<term>Inhibiteurs de la cystéine protéinase</term>
<term>Isoxazoles</term>
<term>Protéines recombinantes</term>
<term>Pyrrolidones</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Isoxazoles</term>
<term>Pyrrolidones</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Isoxazoles</term>
<term>Pyrrolidinones</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Antiviral Agents</term>
<term>Binding Sites</term>
<term>Catalytic Domain</term>
<term>Crystallization</term>
<term>Crystallography, X-Ray</term>
<term>Dimerization</term>
<term>Drug Design</term>
<term>Humans</term>
<term>Models, Molecular</term>
<term>Molecular Sequence Data</term>
<term>Protein Conformation</term>
<term>Protein Structure, Secondary</term>
<term>Protein Structure, Tertiary</term>
<term>Sequence Alignment</term>
<term>Sequence Homology, Amino Acid</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Alignement de séquences</term>
<term>Antiviraux</term>
<term>Chlorométhyl cétones d'acides aminés</term>
<term>Conception de médicament</term>
<term>Conformation des protéines</term>
<term>Cristallisation</term>
<term>Cristallographie aux rayons X</term>
<term>Cysteine endopeptidases</term>
<term>Dimérisation</term>
<term>Domaine catalytique</term>
<term>Données de séquences moléculaires</term>
<term>Humains</term>
<term>Inhibiteurs de la cystéine protéinase</term>
<term>Isoxazoles</term>
<term>Modèles moléculaires</term>
<term>Protéines recombinantes</term>
<term>Pyrrolidones</term>
<term>Similitude de séquences d'acides aminés</term>
<term>Sites de fixation</term>
<term>Structure secondaire des protéines</term>
<term>Structure tertiaire des protéines</term>
<term>Séquence d'acides aminés</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A novel coronavirus has been identified as the causative agent of severe acute respiratory syndrome (SARS). The viral main proteinase (Mpro, also called 3CLpro), which controls the activities of the coronavirus replication complex, is an attractive target for therapy. We determined crystal structures for human coronavirus (strain 229E) Mpro and for an inhibitor complex of porcine coronavirus [transmissible gastroenteritis virus (TGEV)] Mpro, and we constructed a homology model for SARS coronavirus (SARS-CoV) Mpro. The structures reveal a remarkable degree of conservation of the substrate-binding sites, which is further supported by recombinant SARS-CoV Mpro-mediated cleavage of a TGEV Mpro substrate. Molecular modeling suggests that available rhinovirus 3Cpro inhibitors may be modified to make them useful for treating SARS.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Hilgenfeld, Rolf" sort="Hilgenfeld, Rolf" uniqKey="Hilgenfeld R" first="Rolf" last="Hilgenfeld">Rolf Hilgenfeld</name>
<name sortKey="Mesters, Jeroen R" sort="Mesters, Jeroen R" uniqKey="Mesters J" first="Jeroen R" last="Mesters">Jeroen R. Mesters</name>
<name sortKey="Wadhwani, Parvesh" sort="Wadhwani, Parvesh" uniqKey="Wadhwani P" first="Parvesh" last="Wadhwani">Parvesh Wadhwani</name>
<name sortKey="Ziebuhr, John" sort="Ziebuhr, John" uniqKey="Ziebuhr J" first="John" last="Ziebuhr">John Ziebuhr</name>
</noCountry>
<country name="Allemagne">
<noRegion>
<name sortKey="Anand, Kanchan" sort="Anand, Kanchan" uniqKey="Anand K" first="Kanchan" last="Anand">Kanchan Anand</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006039 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006039 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:12746549
   |texte=   Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:12746549" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021